0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CGT CDMO Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-34J6684
Home | Market Reports | Health| Nursing
Global CGT CDMO Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global CGT CDMO Market Research Report 2025

Code: QYRE-Auto-34J6684
Report
March 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CGT CDMO Market Size

The global market for CGT CDMO was valued at US$ 5665 million in the year 2024 and is projected to reach a revised size of US$ 25110 million by 2031, growing at a CAGR of 24.1% during the forecast period.

CGT CDMO Market

CGT CDMO Market

CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.
Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.
This report aims to provide a comprehensive presentation of the global market for CGT CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CGT CDMO.
The CGT CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CGT CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CGT CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CGT CDMO Market Report

Report Metric Details
Report Name CGT CDMO Market
Accounted market size in year US$ 5665 million
Forecasted market size in 2031 US$ 25110 million
CAGR 24.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Immune Cells
  • Stem Cells
  • Viral Vectors
  • Plasmid DNA
Segment by Application
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutions
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis, OBiO, GenScript, Pharmaron, Porton
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CGT CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CGT CDMO Market growing?

Ans: The CGT CDMO Market witnessing a CAGR of 24.1% during the forecast period 2025-2031.

What is the CGT CDMO Market size in 2031?

Ans: The CGT CDMO Market size in 2031 will be US$ 25110 million.

What is the market share of major companies in CGT CDMO Market?

Ans: The top three players hold a share over 60%.

What is the CGT CDMO Market share by region?

Ans: North America is the largest market, has a share about 50%.

What is the CGT CDMO Market share by type?

Ans: In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

Who are the main players in the CGT CDMO Market report?

Ans: The main players in the CGT CDMO Market are Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis, OBiO, GenScript, Pharmaron, Porton

What are the Application segmentation covered in the CGT CDMO Market report?

Ans: The Applications covered in the CGT CDMO Market report are Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Hospital, Others

What are the Type segmentation covered in the CGT CDMO Market report?

Ans: The Types covered in the CGT CDMO Market report are Immune Cells, Stem Cells, Viral Vectors, Plasmid DNA

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGT CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Cells
1.2.3 Stem Cells
1.2.4 Viral Vectors
1.2.5 Plasmid DNA
1.3 Market by Application
1.3.1 Global CGT CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGT CDMO Market Perspective (2020-2031)
2.2 Global CGT CDMO Growth Trends by Region
2.2.1 Global CGT CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CGT CDMO Historic Market Size by Region (2020-2025)
2.2.3 CGT CDMO Forecasted Market Size by Region (2026-2031)
2.3 CGT CDMO Market Dynamics
2.3.1 CGT CDMO Industry Trends
2.3.2 CGT CDMO Market Drivers
2.3.3 CGT CDMO Market Challenges
2.3.4 CGT CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CGT CDMO Players by Revenue
3.1.1 Global Top CGT CDMO Players by Revenue (2020-2025)
3.1.2 Global CGT CDMO Revenue Market Share by Players (2020-2025)
3.2 Global CGT CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CGT CDMO Revenue
3.4 Global CGT CDMO Market Concentration Ratio
3.4.1 Global CGT CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGT CDMO Revenue in 2024
3.5 Global Key Players of CGT CDMO Head office and Area Served
3.6 Global Key Players of CGT CDMO, Product and Application
3.7 Global Key Players of CGT CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CGT CDMO Breakdown Data by Type
4.1 Global CGT CDMO Historic Market Size by Type (2020-2025)
4.2 Global CGT CDMO Forecasted Market Size by Type (2026-2031)
5 CGT CDMO Breakdown Data by Application
5.1 Global CGT CDMO Historic Market Size by Application (2020-2025)
5.2 Global CGT CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CGT CDMO Market Size (2020-2031)
6.2 North America CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CGT CDMO Market Size by Country (2020-2025)
6.4 North America CGT CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CGT CDMO Market Size (2020-2031)
7.2 Europe CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CGT CDMO Market Size by Country (2020-2025)
7.4 Europe CGT CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CGT CDMO Market Size (2020-2031)
8.2 Asia-Pacific CGT CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CGT CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific CGT CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CGT CDMO Market Size (2020-2031)
9.2 Latin America CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CGT CDMO Market Size by Country (2020-2025)
9.4 Latin America CGT CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CGT CDMO Market Size (2020-2031)
10.2 Middle East & Africa CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CGT CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa CGT CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent CGT CDMO Introduction
11.1.4 Catalent Revenue in CGT CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza CGT CDMO Introduction
11.2.4 Lonza Revenue in CGT CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher CGT CDMO Introduction
11.3.4 Thermo Fisher Revenue in CGT CDMO Business (2020-2025)
11.3.5 Thermo Fisher Recent Development
11.4 ACG Biologics
11.4.1 ACG Biologics Company Details
11.4.2 ACG Biologics Business Overview
11.4.3 ACG Biologics CGT CDMO Introduction
11.4.4 ACG Biologics Revenue in CGT CDMO Business (2020-2025)
11.4.5 ACG Biologics Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec CGT CDMO Introduction
11.5.4 WuXi AppTec Revenue in CGT CDMO Business (2020-2025)
11.5.5 WuXi AppTec Recent Development
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River CGT CDMO Introduction
11.6.4 Charles River Revenue in CGT CDMO Business (2020-2025)
11.6.5 Charles River Recent Development
11.7 Oxford Biomedica (OXB)
11.7.1 Oxford Biomedica (OXB) Company Details
11.7.2 Oxford Biomedica (OXB) Business Overview
11.7.3 Oxford Biomedica (OXB) CGT CDMO Introduction
11.7.4 Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2020-2025)
11.7.5 Oxford Biomedica (OXB) Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis CGT CDMO Introduction
11.8.4 Novartis Revenue in CGT CDMO Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 OBiO
11.9.1 OBiO Company Details
11.9.2 OBiO Business Overview
11.9.3 OBiO CGT CDMO Introduction
11.9.4 OBiO Revenue in CGT CDMO Business (2020-2025)
11.9.5 OBiO Recent Development
11.10 GenScript
11.10.1 GenScript Company Details
11.10.2 GenScript Business Overview
11.10.3 GenScript CGT CDMO Introduction
11.10.4 GenScript Revenue in CGT CDMO Business (2020-2025)
11.10.5 GenScript Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron CGT CDMO Introduction
11.11.4 Pharmaron Revenue in CGT CDMO Business (2020-2025)
11.11.5 Pharmaron Recent Development
11.12 Porton
11.12.1 Porton Company Details
11.12.2 Porton Business Overview
11.12.3 Porton CGT CDMO Introduction
11.12.4 Porton Revenue in CGT CDMO Business (2020-2025)
11.12.5 Porton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global CGT CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immune Cells
 Table 3. Key Players of Stem Cells
 Table 4. Key Players of Viral Vectors
 Table 5. Key Players of Plasmid DNA
 Table 6. Global CGT CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global CGT CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global CGT CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global CGT CDMO Market Share by Region (2020-2025)
 Table 10. Global CGT CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global CGT CDMO Market Share by Region (2026-2031)
 Table 12. CGT CDMO Market Trends
 Table 13. CGT CDMO Market Drivers
 Table 14. CGT CDMO Market Challenges
 Table 15. CGT CDMO Market Restraints
 Table 16. Global CGT CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global CGT CDMO Market Share by Players (2020-2025)
 Table 18. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2024)
 Table 19. Ranking of Global Top CGT CDMO Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by CGT CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of CGT CDMO, Headquarters and Area Served
 Table 22. Global Key Players of CGT CDMO, Product and Application
 Table 23. Global Key Players of CGT CDMO, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global CGT CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global CGT CDMO Revenue Market Share by Type (2020-2025)
 Table 27. Global CGT CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global CGT CDMO Revenue Market Share by Type (2026-2031)
 Table 29. Global CGT CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global CGT CDMO Revenue Market Share by Application (2020-2025)
 Table 31. Global CGT CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global CGT CDMO Revenue Market Share by Application (2026-2031)
 Table 33. North America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific CGT CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific CGT CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific CGT CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Catalent Company Details
 Table 49. Catalent Business Overview
 Table 50. Catalent CGT CDMO Product
 Table 51. Catalent Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 52. Catalent Recent Development
 Table 53. Lonza Company Details
 Table 54. Lonza Business Overview
 Table 55. Lonza CGT CDMO Product
 Table 56. Lonza Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 57. Lonza Recent Development
 Table 58. Thermo Fisher Company Details
 Table 59. Thermo Fisher Business Overview
 Table 60. Thermo Fisher CGT CDMO Product
 Table 61. Thermo Fisher Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 62. Thermo Fisher Recent Development
 Table 63. ACG Biologics Company Details
 Table 64. ACG Biologics Business Overview
 Table 65. ACG Biologics CGT CDMO Product
 Table 66. ACG Biologics Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 67. ACG Biologics Recent Development
 Table 68. WuXi AppTec Company Details
 Table 69. WuXi AppTec Business Overview
 Table 70. WuXi AppTec CGT CDMO Product
 Table 71. WuXi AppTec Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 72. WuXi AppTec Recent Development
 Table 73. Charles River Company Details
 Table 74. Charles River Business Overview
 Table 75. Charles River CGT CDMO Product
 Table 76. Charles River Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 77. Charles River Recent Development
 Table 78. Oxford Biomedica (OXB) Company Details
 Table 79. Oxford Biomedica (OXB) Business Overview
 Table 80. Oxford Biomedica (OXB) CGT CDMO Product
 Table 81. Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 82. Oxford Biomedica (OXB) Recent Development
 Table 83. Novartis Company Details
 Table 84. Novartis Business Overview
 Table 85. Novartis CGT CDMO Product
 Table 86. Novartis Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 87. Novartis Recent Development
 Table 88. OBiO Company Details
 Table 89. OBiO Business Overview
 Table 90. OBiO CGT CDMO Product
 Table 91. OBiO Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 92. OBiO Recent Development
 Table 93. GenScript Company Details
 Table 94. GenScript Business Overview
 Table 95. GenScript CGT CDMO Product
 Table 96. GenScript Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 97. GenScript Recent Development
 Table 98. Pharmaron Company Details
 Table 99. Pharmaron Business Overview
 Table 100. Pharmaron CGT CDMO Product
 Table 101. Pharmaron Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 102. Pharmaron Recent Development
 Table 103. Porton Company Details
 Table 104. Porton Business Overview
 Table 105. Porton CGT CDMO Product
 Table 106. Porton Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
 Table 107. Porton Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. CGT CDMO Picture
 Figure 2. Global CGT CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CGT CDMO Market Share by Type: 2024 VS 2031
 Figure 4. Immune Cells Features
 Figure 5. Stem Cells Features
 Figure 6. Viral Vectors Features
 Figure 7. Plasmid DNA Features
 Figure 8. Global CGT CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global CGT CDMO Market Share by Application: 2024 VS 2031
 Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 11. Research and Academic Institutions Case Studies
 Figure 12. Hospital Case Studies
 Figure 13. Others Case Studies
 Figure 14. CGT CDMO Report Years Considered
 Figure 15. Global CGT CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global CGT CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global CGT CDMO Market Share by Region: 2024 VS 2031
 Figure 18. Global CGT CDMO Market Share by Players in 2024
 Figure 19. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by CGT CDMO Revenue in 2024
 Figure 21. North America CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America CGT CDMO Market Share by Country (2020-2031)
 Figure 23. United States CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe CGT CDMO Market Share by Country (2020-2031)
 Figure 27. Germany CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific CGT CDMO Market Share by Region (2020-2031)
 Figure 35. China CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America CGT CDMO Market Share by Country (2020-2031)
 Figure 43. Mexico CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa CGT CDMO Market Share by Country (2020-2031)
 Figure 47. Turkey CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Catalent Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 51. Lonza Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 52. Thermo Fisher Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 53. ACG Biologics Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 54. WuXi AppTec Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 55. Charles River Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 56. Oxford Biomedica (OXB) Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 57. Novartis Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 58. OBiO Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 59. GenScript Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 60. Pharmaron Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 61. Porton Revenue Growth Rate in CGT CDMO Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Medical Simulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-7S2681
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Patient-derived Xenograft (PDX) Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22N5886
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Defensin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24X10377
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Acupuncture Needles Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-27A351
Wed Mar 19 00:00:00 UTC 2025

Add to Cart